Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-08-07
2007-08-07
Wessendorf, T. D. (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C453S006000, C453S004000, C453S061000, C453S007000, C453S007000, C453S037000, C453S037000, C530S317000
Reexamination Certificate
active
10422536
ABSTRACT:
The present invention relates to methods and compositions utilizing inteins to generate libraries of cyclic peptides in vivo. The prevent invention also relates to methods for inhibiting protein-protein interaction.
REFERENCES:
patent: 6153380 (2000-11-01), Nolan et al.
patent: 6531316 (2003-03-01), Pattern et al.
patent: 6919184 (2005-07-01), Issakani et al.
patent: 2003/0068649 (2003-04-01), Doberstein et al.
patent: 2004/0053324 (2004-03-01), Wong
patent: 2004/0180353 (2004-09-01), Booher
patent: WO 00/36093 (2000-06-01), None
patent: WO 01/57183 (2001-08-01), None
Tanaka et al, Mol. Cells. 8(5), 503-512 (1998).
Brennand, D.M., et al., “Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNS synthesis in human fibroblasts,”FEBS Lett.413(1):70-74 (Aug. 1997).
Camarero, J.A., et al., “Biosynthesis of a Head-to-Tail Cyclized Protein with Improved Biological Activity,”J. Am. Chem. Soc.121(23):5597-5598 (Jun. 1999).
Camarero, J.A., et al., “Chemical Synthesis of a Circular Protein Domain: Evidence for Folding-Assisted Cyclization,”Angew. Chem. Int. Ed.37(3):347-349 (Feb. 1998).
Eriksson, J.E., et al., “Rapid microfilament reorganization induced in isolated rat hepatocytes by microcystin-LR, a cyclic peptide toxin,”Exp. Cell. Res.185(1):86-100 (Nov. 1989).
Evans, T.C., et al., “The cyclization and polymerization of bacterially expressed proteins using modified self-splicing inteins,”J. Biol. Chem.274(26):18359-18363 (Jun. 1999).
Evans, T.C., et al., “Proteintrans-Splicing and Cyclization by a Naturally Split Intein from thednaEGene ofSynechocystisSpecies PCC6803,”J. Biol. Chem.275(13):9091-9094 (Mar. 2000).
Evans, T.C., et al., “Semisynthesis of cytotoxic proteins using a modified protein splicing element,”Protein Sci.7(11):2256-2264 (Nov. 1998).
Friedler, A., et al., “Backbone cylic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells,”Biochemistry37(16):5616-5622 (Apr. 1998).
Goldenberg, D.P., et al., “Circular and circularly permuted forms of bovine pancreatic trypsin inhibitor,”J. Mol. Biol.165(2):407-413 (Apr. 1983).
Hruby, V.J., et al., “Conformational restrictions of biologically active peptides via amino acid side chain groups,”Life Sci.31(3):189-199 (Jul. 1982).
Hruby, V.J., et al., “Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical, and dynamic considerations,”Biochem. J.268(2):249-262 (Jun. 1990).
Iwai, H., et al., “Circular β-lactamase: stability enhancement by cyclizing the backbone,”FEBS Lett.459(2):166-172 (Oct. 1999).
Jackson, D.Y., et al., “Enzymatic Cyclization of Linear Peptide Esters Using Subtiligase,”J. Am. Chem. Soc.117(2):819-820 (Jan. 1995).
Jois, S.D., et al., “A Ca2+binding cyclic peptide from the α-subunit of LFA-1: inhibitor of ICAM-1/LFA-1-mediated T-cell adhesion,”J. Peptide Res.53(1): 18-29 (Jan. 1999).
Kimura, K., et al., “Propeptin, a new inhibitor of prolyl endopeptidase produced byMicrobiospora.I. Fermentation, isolation and biological properties,”J. Antibiot.(Tokyo) 50(5):373-378 (May 1997).
Koivunen, E., et al., “Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins,”Biotechnology13(3):265-270 (Mar. 1995).
Scott, C.P., et al., “Production of cyclic peptides and proteins in vivo,”Proc. Natl. Acad. Sci. USA96(24):13638-13643 (Nov. 1999).
Southworth, M.W., et al., “Control of protein splicing by intein fragment reassembly,”EMBO J.17(4):918-926 (Feb. 1998).
Tam, J.P., et al., “A biomimetic strategy in the synthesis and framentation of cyclic protein,”Protein Sci.7(7):1583-1592 (Jul. 1998).
Wood, D.W., et al., “A genetic system yields self-cleaving inteins for bioseparations,”Nat. Biotechnol.17(9):889-892 (Sep. 1999).
Zhang, L., et al., “Synthesis and Application of Unprotected Cyclic Peptides as Building Blocks for Peptide Dendrimers,”J. Am. Chem. Soc.119(10):2363-2370 (Mar. 1997).
Bennett Mark K.
Kinsella Todd M.
Lorens James B.
Pray Todd
Diehl James J.
Francis Carol L.
Keddie James S.
Rigel Pharmaceuticals Inc.
Wessendorf T. D.
LandOfFree
In vivo production of cyclic peptides for inhibiting... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vivo production of cyclic peptides for inhibiting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vivo production of cyclic peptides for inhibiting... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3868830